Home » Stocks » Masimo

Masimo Corporation (MASI)

Stock Price: $214.09 USD 0.14 (0.07%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 11.76B
Revenue (ttm) 1.05B
Net Income (ttm) 222.23M
Shares Out 54.95M
EPS (ttm) 3.87
PE Ratio 55.32
Forward PE 59.17
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $214.09
Previous Close $213.95
Change ($) 0.14
Change (%) 0.07%
Day's Open 215.40
Day's Range 212.22 - 216.74
Day's Volume 264,503
52-Week Range 139.36 - 258.00

More Stats

Market Cap 11.76B
Enterprise Value 11.08B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 54.95M
Float 50.76M
EPS (basic) 4.12
EPS (diluted) 3.87
FCF / Share 2.82
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.81%
FCF Yield 1.31%
Payout Ratio n/a
Shares Short 1.35M
Short Ratio 2.37
Short % of Float 2.67%
Beta 0.87
PE Ratio 55.32
Forward PE 59.17
P/FCF Ratio 76.09
PS Ratio 11.23
PB Ratio 8.74
Revenue 1.05B
Operating Income 244.42M
Net Income 222.23M
Free Cash Flow 154.61M
Net Cash 681.88M
Net Cash / Share 12.41
Gross Margin 60.09%
Operating Margin 23.34%
Profit Margin 21.20%
FCF Margin 14.77%
ROA 10.64%
ROE 18.64%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 3
Overweight 1
Hold 2
Underweight 1
Sell 0

Analyst Consensus: Overweight

Price Target

$252.25*
(17.82% upside)
Low
242
Current: $214.09
High
262
Target: 252.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue938858790713630587547493439405
Revenue Growth9.27%8.61%10.85%13.14%7.41%7.2%10.95%12.36%8.28%-
Gross Profit629575522478410391359326294286
Operating Income22120818443612010479.7285.2386.52106
Net Income19619412531183.3072.5258.3862.2763.7073.53
Shares Outstanding53.4352.3051.5249.5351.3154.7156.6957.4559.6658.77
Earnings Per Share3.443.452.235.851.551.301.021.071.051.21
EPS Growth-0.29%54.71%-61.88%277.42%19.23%27.45%-4.67%1.9%-13.22%-
Dividend Per Share-------1.00-2.75
Operating Cash Flow22224056.0641911795.6155.1075.1278.9661.02
Capital Expenditures-68.38-17.13-43.68-19.71-50.39-75.06-9.43-10.52-5.06-9.56
Free Cash Flow15322212.3839966.8120.5545.6864.6173.9051.46
Cash & Equivalents68855231530613213495.4771.5513088.31
Total Debt---0.071851250.340.120.120.17
Net Cash / Debt688552315306-52.839.2395.1371.4413088.13
Assets1,3961,155905821602565439375366310
Liabilities22818618126032625711298.9986.4480.20
Book Value1,168969724560275306326273277228
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Masimo Corporation
Country United States
Employees 1,600
CEO Joe E. Kiani

Stock Information

Ticker Symbol MASI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: MASI
IPO Date August 8, 2007

Description

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.